Last reviewed · How we verify

NCT05763966: UPC

Uppsala Psychosis Cohort

Recruiting now Last updated 20 February 2025
What this trial tests

trial testing No intervention in Schizophrenia; Psychosis in 120 participants. Currently enrolling.

Timeline
1 April 2023
Primary endpoint
31 December 2026
31 December 2031

Quick facts

Lead sponsorUppsala University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment120
Start date1 April 2023
Primary completion31 December 2026
Estimated completion31 December 2031
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Uppsala University

Who can join

Adults 18 to 40, any sex, with Schizophrenia; Psychosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A multimodal longitudinal study in early stage psychosis patients and individuals at high risk for psychosis. Healthy controls are included for baseline comparisons. The aim is to investigate disease mechanisms of psychotic disorders, specifically focusing on the synaptic pruning hypothesis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Schizophrenia; Psychosis

Currently open trials in the same condition.

Other Uppsala University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05763966.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing